spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

SCORR Marketing and Applied Clinical Trials Release Report on Collaborative R&D in the Drug Development Industry

Applied Clinical Trials

Study on collaboration in the life sciences industry

Industry Kearney, Neb., Oct. 18, 2017

SCORR Marketing, a global health science marketing and communications firm, and Applied Clinical Trials have released a new study, Collaborative R&D Survey Report. The report details the extent to which collaboration in the life sciences industry occurs and provides insight into the factors that influence this collaboration.

“To fight the growing complexity and costs of drug development, drug sponsors are turning to a variety of strategies, one of which is collaborating on research and development (R&D),” said Anne-Marie Hess, senior strategic advisor at SCORR. “To help the industry better understand this strategy, we gathered information about attitudes toward collaborative R&D, its benefits and risks, which groups participate in such collaborations and why some partnerships are more productive than others.”

In addition, this report has information on why those in the industry think these arrangements are increasing, which stakeholders are more receptive to R&D partnerships and what types of medicines, therapeutic areas and medical devices will see more research and development through collaboration in the years ahead.

“Shared expertise and more efficient resource allocation were the two greatest perceived benefits of collaborative R&D,” said Lisa Henderson, group content director, Applied Clinical Trials, and Pharmaceutical Executive at UBM Americas. “What surprised us throughout the survey was the large discrepancy we found in some areas based on the respondents’ demographics — where their company was headquartered, the size of their company and their particular field.”

About SCORR Marketing
SCORR Marketing is the leading marketing and communications firm in the health sciences industry. We partner with organizations involved in global research, development and commercialization of biopharmaceutical and device products and the delivery of health care products and services. At SCORR, we achieve results for our clients by applying our proven, disciplined approach to synthesize market intelligence, strategy and creativity. We have locations across North America and Europe. For more information, visit www.scorrmarketing.com.
email lisa.henderson@ubm.com
email 485 Route 1 South Building F, Suite 210 Iselin, NJ 08830
 
Print this page
Send to a friend
   
spacer
News and Press Releases

BioIVT Publishes New Research On the Mechanisms Underlying the C-DILI Assay

BioIVT, a leading provider of research models and services for drug development, today announced its research into the mechanisms involved in cholestatic drug-induced liver injury (DILI) has been published in Applied In Vitro Toxicology.1
More info >>


White Papers

7 Common Myths about QP Training Debunked: A Guide for Senior Managers

RSSL

The role of the Qualified Person (QP) in the pharmaceutical industry is mandated by law (Directive 2001/83/EC, Directive 2001/20/EC, UK SI 2012/1916, UK SI 2004/103). Every holder of a relevant Manufacturers Authorisation (human and veterinary) must have at least one QP; without one, no batch of medicinal product can be certified for release for sale.
More info >>

Industry Events

SMI Immuno-Oncology Conference

25-27 September 2018, Copthorne Tara Hotel, London, UK

Immuno-Oncology is a fast-paced field with massive potential to deliver successful and durable cancer therapies, and SMi's Immuno-Oncology Conference will focus on a few key areas of the field with a representation of the whole industry under each area. These areas will be drawn together to look towards the future of Immuno-oncology and how the field can progress.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement